Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schuler-Thurner

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 4, 2008
Dendritic cell vaccines in metastasized malignant melanomaM Erdmann, B Schuler-Thurner
Cell|August 18, 2001
Dendritic cells as vectors for therapyJ Banchereau, B Schuler-Thurner, A K Palucka, et al.
International Immunology|November 22, 2001
Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturationJ Li, B Schuler-Thurner, G Schuler, et al.
Gene Therapy|March 20, 2015
A new method to monitor antigen-specific CD8+ T cells, avoiding additional target cells and the restriction to human leukocyte antigen haplotypeS Prommersberger, S Höfflin, B Schuler-Thurner, et al.
Transfusion|February 13, 2001
Collection of MNCs with two cell separators for adoptive immunotherapy in patients with stage IV melanomaA Glaser, B Schuler-Thurner, B Feuerstein, et al.
International Journal of Cancer|December 18, 2001
Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progressionM H Andersen, P Keikavoussi, E B Bröcker, et al.
Nuklearmedizin. Nuclear Medicine|March 21, 2006
Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patientsW Römer, A Nömayr, H Greess, et al.
Current Biology : CB|August 30, 2001
A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cellsO T Fackler, D Wolf, H O Weber, et al.
Journal of Immunological Methods|October 24, 2000
A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical useB Feuerstein, T G Berger, C Maczek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cellsB Schuler-Thurner, D Dieckmann, P Keikavoussi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 4, 2008
Dendritic cell vaccines in metastasized malignant melanomaM Erdmann, B Schuler-Thurner
Cell|August 18, 2001
Dendritic cells as vectors for therapyJ Banchereau, B Schuler-Thurner, A K Palucka, et al.
International Immunology|November 22, 2001
Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturationJ Li, B Schuler-Thurner, G Schuler, et al.
Gene Therapy|March 20, 2015
A new method to monitor antigen-specific CD8+ T cells, avoiding additional target cells and the restriction to human leukocyte antigen haplotypeS Prommersberger, S Höfflin, B Schuler-Thurner, et al.
Transfusion|February 13, 2001
Collection of MNCs with two cell separators for adoptive immunotherapy in patients with stage IV melanomaA Glaser, B Schuler-Thurner, B Feuerstein, et al.
International Journal of Cancer|December 18, 2001
Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progressionM H Andersen, P Keikavoussi, E B Bröcker, et al.
Nuklearmedizin. Nuclear Medicine|March 21, 2006
Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patientsW Römer, A Nömayr, H Greess, et al.
Current Biology : CB|August 30, 2001
A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cellsO T Fackler, D Wolf, H O Weber, et al.
Journal of Immunological Methods|October 24, 2000
A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical useB Feuerstein, T G Berger, C Maczek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cellsB Schuler-Thurner, D Dieckmann, P Keikavoussi, et al.
Pageof 2